Hematologic Complications of Pregnancy
Section snippets
Iron Deficiency
The most frequent hematologic complication during pregnancy is anemia. A number of normal physiologic processes occur during pregnancy leading to the term “physiologic anemia of pregnancy.” The plasma volume increases (40%–50%) relative to red blood cell mass (20%–30%) and accounts for the fall in hemoglobin concentration.1 However, if the hemoglobin falls below 11 g/dL, an evaluation for iron deficiency anemia (IDA) should be initiated since iron deficiency is responsible for the majority of
Differential Diagnosis of Thrombocytopenia in Pregnancy
Similar to the finding of anemia in pregnancy, thrombocytopenia is also common, occurring in approximately 8%–10% of pregnancies,21 and usually secondary to physiologic changes during gestation, namely, an increase in blood volume, platelet activation, and increased platelet clearance. Gestational thrombocytopenia accounts for the majority of thrombocytopenias during pregnancy (Table 1) and most cases are mild (100–150,000/μL) and not associated with any adverse events for either the mother or
Bleeding Disorders
Bleeding complications in pregnant women can occur as the result of an inherited or acquired coagulopathy. Acquired bleeding disorders during pregnancy usually arise acutely during massive postpartum hemorrhage when uterotonics or sutures have failed. Over the subsequent 1–4 months following delivery, acquired hemophilia can develop secondary to an antibody against a coagulation factor.
Manifestations of a previously unrecognized bleeding disorder are more likely to manifest in women during
Venous Thromboembolism
The rapid recognition and treatment of venous thromboembolism (VTE) during pregnancy is essential since VTE is a major cause of maternal mortality. The risk of thrombosis increases as pregnancy progresses and subsequently peaks during the puerperium. The elements of Virchow’s triad (hypercoagulability, stasis, endothelial damage) underlie the pathogenesis of VTE in pregnancy. First, the hypercoagulable state is created by an increase in coagulation factors, acquired resistance to activated
Conclusions
Many hematologic problems develop in pregnancy or can be triggered by the pregnant state. Normal physiologic changes during pregnancy can alter hematologic indices during pregnancy and make recognition of pathologic states difficult. Pregnancy can exacerbate underlying hematologic disorders, as well as predispose to life-threatening hematologic emergencies. These conditions are a significant source of morbidity and mortality during pregnancy that has implications for both the mother and the
References (74)
- et al.
Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc
J Am Diet Assoc
(2001) - et al.
Iron supplementation during pregnancy, anemia, and birth weight: a randomized controlled trial
Am J Clin Nutr
(2003) - et al.
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
Am J Clin Nutr
(2003) - et al.
High and low hemoglobin levels during pregnancy: differential risks for preterm birth and small for gestational age
Obstet Gynecol
(2000) Iron status during pregnancy: setting the stage for mother and infant
Am J Clin Nutr
(2005)- et al.
Pregnancy in sickle cell disease: experience of the Cooperative Study of Sickle Cell Disease
Obstet Gynecol
(1996) - et al.
Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia
Am J Obstet Gynecol
(2001) - et al.
Evans' syndrome in pregnancy: a systematic literature review and two new cases
Eur J Obstet Gynecol Reprod Biol
(2010) - et al.
International consensus report on the investigation and management of primary immune thrombocytopenia
Blood
(2010) - et al.
A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura
Blood
(2003)
de Moerloose P. Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia
Obstet Gynecol
How I treat thrombocytopenia in pregnancy
Blood
Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy
J Obstet Gynaecol Can
Laparoscopic splenectomy in a pregnant patient with immune thrombocytopenic purpura
Int J Obstet Anesth
Safety of azathioprine in pregnancy in inflammatory bowel disease
Gastroenterology
Evaluation and management of severe preeclampsia before 34 weeks' gestation
Am J Obstet Gynecol
A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia
Blood
Frequency of inherited bleeding disorders in women with menorrhagia
Lancet
Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease
J Thromb Haemost
The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage
J Thromb Haemost
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
J Thromb Haemost
Thrombotic risk during pregnancy: a population study
Obstet Gynecol
thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Chest
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
Blood
Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study
J Thromb Haemost
Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism
Blood
Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis
J Thromb Haemost
Anemia in pregnancy
Ann N Y Acad Sci
A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy
J Intern Med
Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial
J Matern Fetal Neonat
Outcome of pregnancy in homozygous sickle cell disease
Obstet Gynecol
Morbidity associated with sickle cell disease in pregnancy
Am J Obstet Gynecol
Exposure to hydroxyurea during pregnancy: a case series
Leukemia
Systematic review: hydroxyurea for the treatment of adults with sickle cell disease
Ann Intern Med
Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study
N Engl J Med
Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome
Br J Obster Gynaecol
Cited by (0)
Financial disclosure: The author declares that she has no conflicts of interest or competing financial or personal relationships that could inappropriately influence the content of this article.